Atlas Trials

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

Clinical trial NCT05985707 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05985707
Sponsor
Peking University Cancer Hospital & Institute
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-positive Colorectal CancerHER2-positive Biliary Tract Cancer
Start date
2023-08-15
Primary completion
2026-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.